Dendritic cells isolated from the brains of tumor bearing animals were assessed for expression of known activation markers, including CD80 (B7-1), CD86 (B7-2), and I-Ab major histocompatibility complex (MHC) class II. This evidence concerns the gene CD80 and neoplasm.